Next 10 |
home / stock / rmd / rmd articles
Neogen Corporation (NASDAQ: NEOG) effectively progresses with its strategic growth pillars, placing the company well for future success. The A...
SAN DIEGO, July 03, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE:RMD, ASX: RMD)) today announced it plans to release financial and operational results ...
ResMed (NYSE:RMD) has outperformed the market over the past 15 years by 3.3% on an annualized basis producing an average annual return of 16.26%. C...
QIAGEN N.V. (NYSE: QGEN) recently lauded the new guidelines in the United States that recommend screening at-risk children of all ages for lat...
Charles River Laboratories' (NYSE: CRL) Research Models and Services (RMS) business continues to benefit from the Charles River Accelerator and...
Following three years of nonstop regulatory hassles, Illumina (NASDAQ: ILMN) finally gave up on GRAIL (NASDAQ: GRAL), leading to the successful com...
Abbott's (NYSE: ABT) diversified business portfolio is well-positioned to drive continued momentum in 2024. However, a challenging macroeconomi...
ResMed, Inc. (NYSE:RMD) stock is trading lower Monday after Eli Lilly and Company (NYSE:LLY) released data from a clinical trial in regards to the ...
U.S. stocks were mixed, with the Dow Jones index gaining around 300 points on Monday. Shares of ResMed Inc. (NYSE:RMD) fell sharply during Monday...
News, Short Squeeze, Breakout and More Instantly...
2024-06-29 05:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SAN DIEGO, June 10, 2024 (GLOBE NEWSWIRE) -- In collaboration with leading medical researchers from around the world, ResMed (NYSE: RMD, ASX: RMD) presented 13 new clinical studies at SLEEP 2024, the annual joint meeting of the American Academy of Sleep Medicine and the Sleep Research Society. He...
Among 26 ResMed-supported abstracts, these were the highlights: New findings show positive airway pressure (PAP) therapy reduced risks of death and hospitalization for patients with obstructive sleep apnea (OSA) Prevalence of OSA in the United States expected to increase 26.7%...